ASSERTIO THERAPEUTICS, INC. Deferred Tax Assets, in Process Research and Development
ASSERTIO THERAPEUTICS, INC. had Deferred Tax Assets, in Process Research and Development of $180.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2017-02-24
- 2016-12-31: Deferred Tax Assets, in Process Research and Development $180.00K.
- 2015-12-31: Deferred Tax Assets, in Process Research and Development $253.00K.
- 2014-12-31: Deferred Tax Assets, in Process Research and Development $330.00K.
- 2013-12-31: Deferred Tax Assets, in Process Research and Development $665.00K.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2016-12-31 | $180.00K 10-K · filed 2017-02-24 |
| 2015-12-31 | $253.00K 10-K · filed 2017-02-24 |
| 2014-12-31 | $330.00K 10-K · filed 2016-02-26 |
| 2013-12-31 | $665.00K 10-K · filed 2015-02-26 |
| 2012-12-31 | $1.10M 10-K · filed 2014-03-17 |
| 2011-12-31 | $1.50M 10-K · filed 2013-02-22 |